Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity

Mahsa Eskandari ¹ , Ali Awsat Mellati ² *

Cited by CrossRef: 1

1- Nazeri Z, Mohammadzadeh G, Rashidi M, Azizdoost S, Cheraghzadeh M, Kheirollah A. 24-hydroxycholesterol moderates the effects of amyloid-β on expression of HMG-CoA reductase and ABCA1 proteins in mouse astrocytes. Adv Biomed Res. 2023;12(1):167 [Crossref]

2- Zhang R, Wuerch E, Yong V, Xue M. LXR agonism for CNS diseases: promises and challenges. J Neuroinflammation. 2024;21(1) [Crossref]

3- Xu Y, Xu L, Xu C, Zhao M, Xu T, Xia L, Wu Y, Cao Y, Han Z. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase. Brain Research Bulletin. 2024;206:110836 [Crossref]